For World CML Day (September 22nd), Nancie Steinberg reflects on living with chronic myeloid leukemia and how a cancer diagnosis ultimately led her from patient to advocate. Fourteen years ago,…
September is recognized as Blood Cancer Awareness Month, a time of year to help spread awareness about blood malignancies among the general public and the medical community. In order to…
The European Parliament has announced that they will be relaunching their "Network of Parliamentary Advocates for Rare Diseases." Its aim is to create a new policy framework which can improve…
According to a story from The ASCO Post, the drug dasatinib (marketed as Sprycel), was officially approved as a treatment for chronic myeloid leukemia by the US Food and Drug…
The Platform Notable's automated technology platform was created to help predict which patients would respond better to which therapies. As no patient is the same, this study is paramount. Notable…
According to a story from cnbc.com, the pharmaceutical company Novartis recently announced that their anticancer drug Tasigna has been approved for the treatment of patients one year or older that…
Determining whether a cancer treatment is having the desired effect can be a tricky science. New research by a team from the Keck School of Medicine of USC leverages characteristics…
This past August, NHL veteran Brian Boyle was tired, but as a father of two children, being tired didn’t really surprise him. It was a diagnosis of chronic myelogenous leukemia…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
